Filter
213
Text search:
inactivation
Featured
Recommendations
39
New Publications
45
Language
Document type
Guidelines
83
No document type
82
Manuals
22
Studies & Reports
16
Strategic & Response Plan
3
Fact sheets
3
Training Material
2
Brochures
1
Situation Updates
1
Countries / Regions
Syria
6
Kenya
6
South Africa
6
Russia
6
Sierra Leone
5
India
5
Latin America and the Carribbean
5
Guinea
4
Liberia
4
Nigeria
4
Congo, Democratic Republic of
4
Ethiopia
4
Germany
4
Yemen
4
Middle East and North Africa
4
Western and Central Europe
4
Global
4
Burkina Faso
3
Senegal
3
Côte d’Ivoire / Ivory Coast
3
Ghana
3
Rwanda
3
Mali
2
USA
2
Uganda
2
Chad
2
Brazil
2
Eastern Europe and Central Asia
2
Spain
2
Morocco
1
Saudi Arabia
1
Cameroon
1
Niger
1
Philippines
1
Nepal
1
Pakistan
1
South Sudan
1
Iraq
1
Tanzania
1
Mozambique
1
Sudan
1
Benin
1
North Macedonia
1
Ecuador
1
Angola
1
West and Central Africa
1
Western Pacific Region
1
Authors & Publishers
Publication Years
Category
Countries
49
Clinical Guidelines
31
Key Resources
24
Pharmacy & Technologies
14
Public Health
6
Women & Child Health
4
Capacity Building
2
Toolboxes
COVID-19
69
Rapid Response
24
Ebola
19
Pharmacy
13
TB
11
AMR
10
Zika
8
Caregiver
6
Specific Hazards
5
Planetary Health
4
Conflict
3
NTDs
3
Cholera
2
Polio
2
Natural Hazards
1
HIV
1
Mental Health
1
NCDs
1
La résistance aux antimicrobiens (ou RAM, cette abréviation étant est ici également employée en mode adjectif pour désigner les organismes « résistants aux antimicrobiens ») est une préoccupation majeure pour la santé publique mondiale et une question de sécurité san
...
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to
...
Este documento ha sido revisado y aprobado por la Ponencia de Alertas y Planes de Preparación y Respuesta. Este protocolo está en revisión permanente en función de la evolución y nueva información que se disponga de la infección por el nuevo coronavirus (SARS-CoV-2 ) .
La evolución de los acontecimientos y el esfuerzo conjunto de la comunidad científica mundial, hangeneradogran cantidad de información que se modificarápidamente con nuevas evidencias. Este documento pretende hacer unresumen analítico de la evidencia científica dispo
...
El 31 de diciembrede 2019 las Autoridades de la República Popular China, comunicaron a la OMS varios casos de neumonía de etiología desconocida en Wuhan, una ciudad situada en la provincia china de Hubei. Una semana más tarde confirmaron que se trataba de un nuevo co
...
Outline
• Welcome and objectives
• Microbiology, epidemiology and clinical presentation
• Surveillance for imported cases including case definitions
• Laboratory diagnosis • Infection prevention and hospital readiness
• Patient flow and actions required at each step
• Co-ord
...
Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-
...
COVID-19: Guidelines for case-finding, diagnosis, management and public health response in South Africa
recommended
The information contained in this document, be it guidelines, recommendations, diagnostic algorithms or treatment regimens, are offered in this document in the public interest. To the best of the knowledge of the guideline writing team, the information contained in these guidelines is correct. Imple
...
The current document is anupdate of the guidelines developed by the EUCAST subcommittee on detection of resistance mechanisms. The EUCAST Steering Committee has carried out the current update. The document has been developed mainly for routine use in clinical laboratories and doesnot cover technical
...
Временное руководство
6 апреля 2020 г.
В настоящем документе кратко изложены рекомендации ВОЗ по рациональному использованию средств индивидуальной защиты (СИЗ) в
...
23 December 2020 This document summarizes WHO recommendations for the rational use of personal protective equipment (PPE) in health care settings and temporary strategies during acute supply shortages. This document also contains 2 Annex sections describing updated PPE use recommendations for health
...
This document sets out the preparedness and response plan of the Nigerian Primary Health Care System for COVID-19 Acute Respiratory Disease. It outlines the planning scenarios, key areas of work and priority activities required for the Primary Health Care Sector to quickly scale up its core capacity
...
Orientations provisoires
6 avril 2020
Le présent document résume les recommandations de l’OMS sur l’utilisation rationnelle de l’équipement de protection individuelle (EPI) dans les établissements de santé et lors des soins à domicile, ainsi que lors de la manipulation des cargaison
...
Orientations provisoires
1er avril 2020
Les États Membres doivent améliorer les pratiques d’hygiène des mains de manière ambitieuse afin d’aider à prévenir la transmission du virus de la COVID-19 :
1. en fournissant un accès universel à des postes publics d’hygiène des mains et
...
orientaciones provisionales, 23 de abril de 2020
Eau, assainissement, hygiène et gestion des déchets en rapport avec le virus responsable de la COVID-19
recommended
orientations provisoires, 23 avril 2020
Orientações provisórias23 de Abrilde2020
Accessed: 02.05.2020
These consolidated guidelines provide recommendations for comprehensive prevention and case management strategies in Kenya
Scope of the Guidelines: Infection prevention and control Patient triage Emergency Medical Services Case management Laboratory testing algorithm
Target
...
Accessed: 02.05.2020
These interim IPC recommendations for health settings have been developed through the contributions of many individuals and institutions, such as the Centers for Disease Control-Kenya; ITECH; US Agency for International Development (USAID) Medicines, Technologies, and Pharmaceu
...
